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Telemedicine Background
The healthcare industry in the United States is evolving. Greater levels of
technology are constantly being incorporated in care delivery models and virtually every
layer of healthcare operations. Physicians are commonly managing their patient’s records
via robust electronic health records (EHRs) and most facilities have enabled patient
portals that allow patients to communicate with their providers easily and from anywhere
with Internet access. Web-based portals are a medium for patients to easily connect to
their care team, and their personal health information (PHI). They can also be used to
accomplish tasks such as scheduling, prescription refills, and referral requests. As the
EHRs evolve, the process of healthcare delivery and health management are becoming
increasingly efficient, allowing the delivery of care to become more patient centric. In
many cases patients can remain at home, and focus on their personal recovery efforts
while on site providers access the vital patient information via home-based device,
ensuring proper care is being delivered.
EHRs are much more than a digital version of the traditional paper chart; these
systems facilitate data collection with structured notes, reminders, and clinical decision
making tools. These information systems provide clinical and administrative staff greater
and more efficient access to those data needed for their work. The EHR is populated by
data via entry from staff, connected diagnostic devices, and the patient portal. Other data
interface from systems in remote locations. Data also originates from clinical devices
stationed in patients’ homes, or even on the person. These data inform providers, and
allows them to monitor their patients’ conditions from afar. New devices enabling high
quality remote care are being developed and integrated into healthcare delivery models at
a rapidly increasing rate.
Health information technology (HIT) is now integrated with our personal devices.
The ubiquitous smartphone, now capable of remarkably high levels of functionality and
connectivity, has recently gained the attention of the Food and Drug Administration
(FDA) due to potential applications it has for the medical industry. Commensurate with
the emphasis that smart technology developers have placed on health tracking,
smartphone clinical applications are the subject of two recent FDA publications. Both are
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recommendations issued early in February of 2015 to HIT-related industries and related
regulatory bodies, suggesting an official stance regarding usage of mobile medical
applications and smart devices. The FDA maintains that with the specialized medical
builds of smartphones and tablets, these devices, and the networks they operate over,
should be considered “medical device data systems, medical image storage devices, and
medical image communication devices.” (U.S. Department of Health and Human
Services Food and Drug Administration (FDA). 2015, p. 4). In essence, the FDA wants to
reclassify smart devices used to facilitate medical care in any capacity, as clinical
devices, so as to ensure proper regulation, and security measures that govern their use.
The primary objective within the FDA (2015) publications is to highlight that,
the progression to digital health offers the potential for better, more efficient care
and improved health outcomes. To achieve this goal requires that many medical
devices be interoperable with other types of medical devices and with various
types of health information technology. The foundation for such
intercommunication is hardware and software that transfer, store, convert formats,
and display medical device data or medical image data. (p. 4)
Large amounts and various types of data can originate at the patient level and be
used by medical providers. The FDA described this process as being of high value to the
industry, and low risk to both the patients and providers. Provider EHRs are now able to
capture, store, and utilize both audio and image data meaning that the use of these mobile
medical devices has the potential to substantially broaden the range of healthcare
delivery. The list of connected clinical devices grows longer by the day, and includes
devices such as glucometers, biorhythm monitors, and vital monitors, all of which utilize
cloud connectivity to transfer data. The reach of healthcare delivery now extends into the
patients’ homes, remote locations and facilities, and emergency medical transport
vehicles. This is telemedicine, and it now has the potential to connect patients and
providers across the globe (FDA, 2015). An overview of this infrastructure is provided in
Figure 1.
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Telemedicine Definition
Figure 1

(“Compatible Healthcare Devices,” 2015. Retrieved from: http://www.healthcare.omron).
Evolution of Telemedicine
The American Telemedicine Association (ATA) defines telemedicine as
utilization of clinical data “exchanged from one site to another via electronic
communications to improve a patient’s clinical health status. Telemedicine includes a
variety of applications and services using two-way video, smart phones, and wireless
devices.” (American Telemedicine Association (2010). ATA: Defining telemedicine).
Telemedicine has been an area of research for decades, beginning when the
National Aeronautics and Space Administration (NASA) was preparing to send the first
live crews to the moon in the 1960s, then enhanced when the NAVY adopted the
technology for submarine deployments. The early era of civilian telemedicine delivery
began in behavioral healthcare with clinicians conducting medication reviews with
patients unable to maintain regular appointments. As a result, we have a large body of
evidence demonstrating the efficiency and cost effectiveness of various telemedicine
applications. As telecommunications and networking technology evolved, telemedicine
technology followed in kind. Due to sluggish regulations and lack of supportive
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reimbursement, however, clinical telemedicine research and practices are not keeping
pace with the technology (Nicogossian, Pober, & Roy, 2001).
Over the years telemedicine practices were integrated into the operations of
hospitals, specialty departments, home health agencies, and private physician offices.
Technology and processes related to telemedicine are now an important consideration
within larger investment decisions being made by healthcare institutions for both
information technology and the delivery of clinical care. Currently, the most common,
and the only federally recognized model of telemedicine in practice is physician-directed
video consultation (American Hospital Association, 2011).
Telemedicine technology varies greatly. There is such an array of devices,
different builds, and potential system models that could be incorporated into care
delivery, value can only be determined by how well the technology serves the particular
patients and providers. For example, cardiac patients can benefit from connected heart
monitors that push vital data to the physician’s EHR. Diabetic patients benefit from
connected glucometers that push collected data when docked. Patients can be equipped
with insulin pumps that stream real time data to both their Personal Health records
(PHRs) and EHRs. Once data are captured by the EHR, built in clinical decision support
greatly aids in managing risk, alerting clinicians when levels are out of range and
intervention is needed. For example, one company that has focused on innovative
telemedicine builds for the diabetic population is Tidepool. Their vision is to utilize smart
phone technology to enhance the quality of care for diabetics (“Our Mission,” 2015.
Retrieved from http://tidepool.org).
Methods
A literature search through PubMed, a bibliographic database of medical research,
includes over 12,000 citations of published works related to telemedicine. Much of the
recent peer reviewed research focuses on the potential value of telemedicine technology;
many studies report in terms of increasing the quality of care and others publish details
on the potential cost effectiveness of incorporating this technology in care delivery
models. The value of simultaneously increasing value while lowering cost became more
prominent themes in the research released after 2012. This is when reports began
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adopting the language of Patient Protection and Affordable Care Act (ACA) (American
Telemedicine Association, 2015).
Other data sources for this report included marketing publications issued by the
telemedicine developers. Many of the technologies reviewed are in their early release
phase, which necessitated reliance on and review of publications and reports created by
trade associations, e.g. recent American Telemedicine Association (ATA) releases
highlighting the innovations to be showcased at their 2015 conference. These types of
publications were reviewed to gain perspective on the various technologies currently
available, as well as those on the development horizon.
To understand the perspective of HIT experts in Maine, semi-structured key
informant interviews were conducted. Six total informant interviews were held amongst
physicians, hospital and health network administrators, and HIT experts in Maine. The
conflicting impressions and concerns offered by interviewees helped focus this work on
several critical aspects of the work necessary to successfully navigate the integration of
current telemedicine technology into the healthcare delivery infrastructure of Maine.
Scope of Project
Assessing the potential impact telemedicine may have on the future of healthcare
delivery, next generation technologies, and emerging models in response to health care
reform was the focus of this work. This included an array of connected clinical devices,
innovative applications for smartphones and personal computers (PCs), wearable and
implantable electronic medical devices, and cloud-based clinical software. The standouts
came from companies such as Carena and Allscripts, which build software for clinical
communication, consultation, prescribing, next step planning, and scheduling. These
companies are clearly demonstrating that these functions can be safely and efficiently
performed without patients setting foot in a provider's office. Telemedicine, however,
does not need to be limited to communication or data transfer; current technology is
capable of managing remote care delivery, and providing real time clinical decision
support. Maine experts feel this technology possesses the potential to simultaneously
raise the quality of care, while reducing the cost of delivery. What remains unclear is
exactly how, when, and to what degree. With these questions in mind, this project
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explores barriers to telemedicine adoption and meaningful integration with contemporary
healthcare delivery systems.
Reviewed Telemedicine Technologies
An investigation of the next generation of telemedicine technologies revealed
several companies developing applications for use on smart phones and PCs that allow
patients to access providers via Wi-Fi connectivity. One example is Carena’s Virtual
Clinic, which provides access to an in-network specialist after a guided online
registration. Another is DoctorOnDemand.com, which connects patients to medical
doctors, psychologists, and various other clinical experts via smartphone, tablets, or PCs.
This web-based software offers rapid access to care, which includes diagnosis, treatment
plan, and if needed, electronic prescriptions sent to the patient’s chosen pharmacy. All of
this is done in minutes; no more need to take an entire sick day to be seen by a primary
care provider (PCP) the day after contacting their office. If in-person direct care is
needed, patients are linked to the closest available in-network provider.
Outside of the web-based services and clinical applications is a host of connected
devices, sometimes referred to as the “Internet of Things,” a term coined by technology
pioneer, Kevin Ashton, of Cisco (Retrieved from http://www.cisco.com). The Internet of
Things describes familiar devices, now equipped with the ability to connect and push data
to the cloud, or Internet. The concept extends to the medical industry, as bathroom scales,
glucometers, and blood pressure cuffs now make use of wireless technology and microelectromechanical systems to automatically connect and push data to the providers’ EHR.
Intuitive decision support and emergency alert systems are being built into these devices,
which can alert providers to the need for intervention if the device is not used as
prescribed, or if patient data is outside set parameters. Telemedicine technology is being
built into extremely practical, intuitive, and efficient designs for homes, as well as rural,
emergency, and specialized care delivery settings. Of interest to this project is the patient
to provider structured telemedicine builds. The aim is to investigate whether these
devices and software are, or will soon be able to impact health care in Maine in a positive
and meaningful way (“Internet of Things,” 2015. Retrieved from http://www.cisco.com).
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Despite the wide variety within this sector of technology, all facets of
telemedicine hold one core principle in common. At it’s most basic; each build has a two
party design for the exchange of information, where data is either deliberately or
automatically sent from a remotely located patient to the provider, or from the provider to
the patient. This enables patients and providers to remain in their respective locations,
while data is captured, reviewed and acted upon, thus increasing convenience and
efficiency, and quite often reducing cost for all parties involved. For this system to work
as intended, however, both parties must be able and willing to trust, and to navigate, the
technology.
Industry Requirements
For telemedicine to run smoothly, and to be of value to patients and providers,
many conditions must be met. If the cost is high, the requirements are many, and the
interoperability, or data sharing, is problematic or costly, the technology is unlikely to be
adopted. When these conditions have all been met, and the telemedicine technology can
be well integrated into a system of care, it could be of great value to the provider, and
could be life saving for patients. The aim of patient to provider-structured technology is
efficient, patient-centered, and quality-based care delivery. The primary goal is to place
the right data, in the right hands, at the right time so decisions can be made within the
small window of time required for critical intervention.
Areas of concern cited in the literature and by key informants in Maine, which
serve as themes interwoven throughout this report, include access, value, cost, reliability,
and risk. With regards to access, questions raised ask what sort of patients will have
ability to obtain and properly use these technologies? Relative to value and cost, key
questions include how well will the technology interface or interoperate with the
provider’s EHR, and is there a budget to cover the cost of incorporation? In terms of
reliability and risk, issues raised include concern for whether the resultant data can be
trusted, and what is the extent of risk, and who bears that risk when systems go down or
suffer from security breaches? The following sections consider federal and state
telemedicine policies, provisions of meaningful use, telemedicine applications in
emerging delivery models including patient-centered medical homes and accountable
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care organizations, analytics and data and user interfaces, adoption barriers, concluding
with a summary and discussion of findings.
Federal Policy
The healthcare has struggled with the lack of clearly defined state and federal
regulations regarding use and reimbursement for telemedicine services. The Centers for
Medicare and Medicaid Services (CMS) did not issue policy clearly approving
reimbursement for telemedicine to Medicare patients until the inception of the Balanced
Budget Act of 1997. The range of services, and those receiving them, was relatively
constrained until 2001 when CMS broadened the range of services covered and
established procedures. These changes increased types of treatment covered, eligible
providers, and facilities, however, the allowable services were limited to audio and visual
communication between a clinician stationed in a rural care facility also known as Health
Professional Shortage Area (HPSA), and a patient at their home (Centers for Medicaid &
Medicare services, 2015. Retrieved from http://www.cms.org).
The rules for Medicare reimbursement are becoming progressively more inclusive
of telemedicine services each year; however, CMS continues to require that service
include live interactive video sessions, and does not recognize uses where clinicians
monitor and act on data transmitted from patient to provider, via connected device,
telephone, software, or facsimile. Regulations also restrict access to approved patients
and certified providers, and are reimbursable only when both are in pre-approved
locations. Telemedicine services must be at specific health care facilities, deemed as a
rural HPSA.
While the efforts to include provisions for telemedicine from federal and state
sources are underway, public payment and policies lag behind the emerging potential for
information technology. This is evidenced by the lack of inclusion of this technology
within any of the three stages of Meaningful Use. Earlier this year the American Hospital
Association (AHA) released an open letter to CMS with regard to “CMS-1461-P,
Medicare Program; Medicare Shared Savings Program: Accountable Care.” That
communication references several planned initiatives that could be advanced by the
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integration of telemedicine technology. While this author was not able to locate a
response from CMS, the sentiment expressed by the AHA suggests the growing
awareness of the need for specific inclusion of telemedicine within future federal
regulatory structures, which in turn suggests the importance of, and opportunities to
employ this technology to advance the new and evolving goal sets of the ACA and
healthcare structural reforms underway (Lustig, 2012).
Maine Policy and Regulatory Environment
Within Maine, telemedicine is governed the Maine Department of Health and
Human Services, who have designated all sites in Maine’s twelve rural counties as
eligible providers. Currently MaineCare, Maine’s Medicaid program, is significantly
more flexible concerning telemedicine policy compared with other state/federal
regulatory bodies. Home health, behavioral services, and medical providers within rural
HPSAs, are all eligible to bill for provider initiated video conferenced consultation. Other
Telemedicine applications within the state of Maine cannot be billed for, however, but
they can be used to increase the efficiency of care.
Little information was located concerning the private insurance plan telemedicine
benefits and coverage within the United States. Due to the vast number and varied nature
of third-party payer plans, there is minimal standardization on this subject. Furthermore,
because each state governs their own licensing and credential standards regarding
telemedicine providers, as well as allowable services and reimbursable procedures,
cataloging interstate telemedicine provisions is a massive undertaking beyond the scope
of this project.
Under Maine’s health insurance parity law, private insurers are required to
provide coverage of telemedicine services subject to the same contract terms and
conditions as any other healthcare service. For this reason all third party private payers
allow reimbursement for telemedicine, though this is limited to the finite federal
definition, e.g. audiovisual consult. Consult via telemedicine must be provided in a
manner consistent with in-person coverage. A finer detail of note: neither federal
programs nor private payers are required to reimburse for facility or transmission fees,

Gaynor, Macklin; MPH 699 Capstone, p. 11

which complicates the reimbursement and makes providing telemedicine care less
attractive financially (ME Revised Statutes Annotated. Title 24 Sec. 4316 (2012);
retrieved from http://www.telemedicine policy.us & http://legislature.maine.gov).
HIT is being viewed as increasingly more valuable as quality based care delivery
models emerge in response to ACA. Programs such as Meaningful Use, which was a
product of the American Recovery and Reinvestment Act (ARRA), the National
Committee for Quality Assurance’s (NCQA) Patient-Centered Medical Home (PCMH),
and Accountable Care Organizations (ACOs) all stand to benefit from HIT incorporation.
At the core of these ACA respondent models is the Triple Aim, which is a contextual
framework developed by the Institute for Healthcare Improvement (IHI) that describes an
approach to optimizing health system performance. It is IHI’s core tenant that new
designs are needed to assure increases in quality, affordability, and patient experience of
quality care (CMS, 2015. Retrieved from http://www.cms.org; & Institute for Health
Technology Transformation, 2012).
The Affordable Care Act (ACA) provisions are designed to improve the quality
and efficiency of the U.S. healthcare system as well as design strategies to test new
reimbursement and care delivery systems. Integral to these strategies are new metrics to
report and assess provider performance. Results from these assessments will serve to
better inform public reporting programs, payment reform, value-based purchasing, and
overall quality improvement efforts within the healthcare reform efforts. The ACA
includes strategies for strengthening primary care, supporting clinical and patient
decisions via evidence-based information, and enhancing HIT adoption rates.
Telemedicine stands to positively impact each area of this plan, details of which will
evolve within the context of the quality based care delivery programs.
These approaches to quality based care continue to gain traction in American
healthcare delivery, and as a result, technology is becoming an increasingly important
component of the medical industry. HIT includes varied systems and devices involving
the design, development, creation, use and maintenance of information systems for the
healthcare industry. Automated healthcare information systems stand to lower costs,
improve efficiency, and reduce error, while increasing consumer access to care and
improving service.

Gaynor, Macklin; MPH 699 Capstone, p. 12

The federal bodies governing healthcare funding sources are demanding greater
levels of quality and improved patient outcomes. To encourage this shift, reimbursement
policies have been issuing financial rewards based on reports of quality outcomes rather
than simply rewarding volume of procedures performed. In addition, the focus is on
improving access to high quality of care. Many of the thought leaders within the industry
are turning to technology as the means to meet these new goals.
Institute for Health Technology Transformation (2012), have this to say about
healthcare reform, technology, and population health management:
By applying technology to population health strategies to continually identify,
assess, and stratify provider panels, physician groups can use technology and
automation to augment the role of care teams, manage the patient population more
effectively and efficiently, drive better outcomes, and decrease overall cost, as
demanded by new payment incentives focused on value. (p. 19)
Regarding the quality of telemedicine applications, research has shown that there
is no difference in the ability of the provider to obtain clinical information, issue accurate
diagnosis, and produce effective treatment plans, which result in the same desired clinical
outcomes, as compared to in person care. The ATA (2015) conducted a meta-analysis of
the level of quality across telemedicine models in the U.S. The findings indicate
utilization of this technology has resulted in significantly improved clinical outcomes in
overall levels of care. If the regulatory and payment structures align to include the
available technology, telemedicine stands to become a central component of quality
based healthcare reform. As predicted, strategic adoption of telemedicine technology is
becoming a game changer for quality based care models, most specifically for programs
such as Affordable Care Organizations (ACOs), and Patient Centered Medical Homes
(PCMHs) (American Telemedicine Association, 2015; Dellifraine & Dansky, 2008).
Meaningful Use
Within the ARRA, enacted in 2009, the purpose of the Meaningful Use program
is to use health information technology, with specific attention on EHRs, to improve
quality, safety, and efficiency of healthcare delivery. The technology will be used to
reduce health disparities and engage patients, as well as improve care coordination and
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clinical outcomes. The meaningful use program requires providers and facilities to report
more robust data to CMS to feed the analytics intended to leverage federal quality
improvement programs in an effort to elevate overall population health. An example of
these reporting systems is the Physician Quality Reporting System (PQRS), which is a
reporting program newly established and maintained by CMS that uses a combination of
incentive payments and negative payment adjustments to increase electronic reporting of
quality metrics by eligible professionals (CMS, 2015. Retrieved from
http://www.cms.org).
As healthcare organizations navigate the stages of Meaningful Use, they will be
required to integrate increasing levels of HIT into their care delivery models.
Telemedicine technology stands to be an asset within information-driven systems by
serving a larger patient base, more efficiently, while using fewer clinical resources. Data
on these remote encounters can be easily captured, stored, and reported, thus enhancing
Meaningful Use compliance, while simultaneously achieving the program’s aims for
access, quality and cost efficiencies.
Patient Centered Medical Homes
Patient Centered Medical Homes (PCMH) are part of a national effort to reform
primary care delivery. The model places the patient at the center, while coordinating care
management with providers around the individuals’ specific goals for care. Certified
providers are required to meet six standards determined by the National Committee for
Quality Assurance (NCQA) Telemedicine holds the potential to play a vital role in the
support of most, if not all, of the six standards, which are detailed below in Figure 2.
The PCMH model is a promising structure for improving access to high-quality
care for more Americans at lower cost. In 2010 the University of Pittsburg Medical
Center (UPMC) released results on their integration of telemedicine within a PCMH
based pilot program. The study reported significantly lower medical and pharmacy costs,
more efficient service delivery, lower hospital admissions and readmissions, and fewer
emergency department visits, compared with non-participating sites. The network also
reported seeing a 160% return on the technology investment made to meet the
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requirements of PCMH contracts. The study’s authors observed the greatest function
served by the telemedicine program was to close the gap between patients and providers
by fortifying the ambulatory sector with clinical communication, monitoring, and remote
intervention (Rosenberg, Peele, Keyser, McAnallen & Holder, 2012).
Figure 2

(“PCMH standards,” 2015. Retrieved from, http://www.NCQA.org.).

Accountable Care Organization
An Accountable Care Organization (ACO) is a quality oriented care model
characterized by collaboration among providers who are collectively responsible for the
care outcomes of a defined patient population. This payment and delivery model seeks to
tie provider reimbursements to quality metrics while reducing the total cost of care for an
assigned panel of patients. As the support for the ACO model grows, the hope is that
pervasive payment structures for healthcare reimbursement will begin to move away
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from fee for service and trend toward value based compensation. CMS sets the standards
for specific quality metrics that ACOs must meet for their patient populations in order to
qualify for CMS incentive payments. Payment to ACOs is a capitated, or finite sum, that
is allotted to provide care for a specified population, for a prescribed length of time. The
overarching context for this type of organization is a contracted care plan that rewards
providers for improving the quality of care delivered, in the most efficient manner
possible.
ACOs operate within the Medicare Shared Savings Program (MSSP), established
by section 3022 of the Affordable Care Act. The Shared Savings Program is a key
component of the quality reform initiatives within the ACA. Congress created the MSSP
to facilitate coordination and cooperation among providers, and to improve the quality of
care for Medicare patients while reducing costs. This system encourages partnerships
among independent providers willing to accept risk and share savings based on a single
capitated payment. This places emphasis on primary care, an appealing aspect for payers,
who benefit from cost savings and reduction of global risk (CMS, 2015. Retrieved from
http://www.cms.org).
In order to enjoy the shared savings of the MSSP, ACOs also have to meet 33
quality measures and as MSSP states, ACOs must
define processes to promote evidence-based medicine and patient engagement,
report on quality and cost measures, and coordinate care, such as through the use
of telemedicine, remote patient monitoring, and other such enabling
technologies.” (CMS, 2015. Retrieved from http://www.cms.org).
One ACO of note is Eastern Maine Health System’s Beacon Health, which is
producing significantly positive results within Maine. Within the first two years of
operation, Beacon demonstrated improved care coordination, efficiency, and quality;
becoming the only clinically driven NCQA accredited program in the nation to report
demonstration of cost savings. CMS “announced Beacon Health had a shared savings for
performance year one of $2 million. These savings were reinvested in the ACO with 40
percent used to support care coordination functions and responsibilities, and 60 percent
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invested in data analytics and infrastructure” (Building an Accountable System of Care,
2015. Retrieved from http://www.emhs.org).
Analytics
Data Interface: Healthcare analytics is an emerging science most commonly used
by the larger facilities and networks to inform investments and strategies to maximize use
of available resources. This science makes extensive use of data to fuel statistical and
quantitative analyses, as well as for predictive modeling to target specific patient
populations and to identify specific populations’ needs. A typical model for information
flow within patient to provider-structured telemedicine would be data from personal
devices to provider portal cost savings that feed EHRs. All data from the EHR is then
available to feed the analytics services.
Many EHRs and telemedicine systems may feed a single data warehouse, each
with different data transmittal protocols. New technologies are also emerging to facilitate
both the data interfacing and subsequent analytics. For example analytics platform, e.g.
dbMotion, which will facilitates both the data interfacing and the analytics. Allscripts’s
dbMotion provides the foundation of communication in a disconnected industry, one that
will allow for areas like telemedicine growing further. dbMotion connects otherwise
disparate information silos, enabling healthcare organizations to communicate
effectively, both in and outside of network, and to able to meaningfully leverage their
captured data to benefit from better informed clinical process. Additional information
regarding functionality of dbMotion can be seen in Figure 3 (dbMotion Overview, 2015.
Retrieved from http://www.allscripts.com).

Gaynor, Macklin; MPH 699 Capstone, p. 17

Figure 3.

(dbMotion Overview, 2015. Retrieved from http://www.allscripts.com).

PCMH and PQRS data analytics are used to provide a dashboard of physician
quality performance, to track impact and outcomes, and to enable providers to identify
high risk patients and drill down to learn more from available data. As EHRs are being
integrated into health care throughout the U.S., the systems are generating massive
amounts of data. In many cases, however, the quality of these data may be inferior, and
may offer little value to the generating facilities. Analytics service providers clean the
data, meaning they consolidate and reorganize the data into useable information for
facilities, networks, and in a broader sense, the healthcare industry as a whole. These
analyses provide facilities with a clear perspective on operations by tracking utilization
rates and patient behavioral trends, which informs both healthcare provider strategy and
health industry research. Analytics are central to achieving the systematic quality
improvements and cost reductions that are the central goal of the ACA (Dellifraine &
Dansky 2008).
The current limits to interoperability, inherent in disparate proprietary technology
pose significant barriers for telemedicine as a contributor to healthcare analytics.
Developers are actively working to navigate these constraints. Telemedicine builds are
becoming increasingly able to populate providers’ EHRs, though significant gaps remain.
These and other barriers will be discussed in a subsequent section of this report.
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User Interface: As mentioned earlier, both the patient and the provider determine
value for telemedicine technology. Using analytics to stratify and evaluate the needs of
the patient populations will increase the potential of using the appropriate technology to
make the providers better able to serve their patient’s needs, thus increasing the overall
value of the technology itself. To achieve this, it is essential that patients both can, and
will, use their devices as intended. Using an analytics informed process to target users in
the early stages of telemedicine diffusion could reduce the risk of ill-used technology.
This ability to distinguish among patient populations by capacity and level of risk, will
allow developers to design the technology to be of service to those who need it most, as
well as to be of most use to those who will adopt it. For example, wearable devices and
web-based urgent care applications are designed for the active and most fit populations
who will access web-based portals and take action independently. In contrast,
monitoring devices for at risk populations, like technologies designed for diabetic
patients rely on data vital automatically being pushed simultaneously to patients and
their providers (HIMSS Analytics, 2014).
Organizational Interface: The Healthcare Information and Management Systems
Society (HIMSS), a non profit organization focused on better health through information
technology, has developed a model to help optimize HIT outcomes. This design, known as
the Continuity of Care Maturity Model (CCMM), serves as a healthcare network’s guide
for future HIT integration. This model is designed to facilitate greater levels of information
exchange by establishing HIT interoperability, to foster care coordination, as well as
patient engagement; all of which will ultimately raise providers’ capacity to manage
population health. The intent of CCMM is similar to the Meaningful Use program, with the
most notable difference being CCMM’s emphasis on a seamless HIT interface and EHR
optimization informed by extensive analytics. Figure 4, describes the eight stages of the
CCMM model (HIMSS Analytics Stage 7, 2015. Retrieved from http://himssanalytics.org).
As a direct result of the information made available via analytics, patients can
now be efficiently categorized and evaluated, allowing delivery of care to be more
precisely targeted, and impactful. Users can now know the level of monitoring required
by each patient group, progress toward implementation of specific interventions and
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evidence-based practices associated with various clinical scenarios. This use of
information helps demonstrate why telemedicine technology is viewed as having such
high potential value. Health systems are rapidly learning how, when, and where to
employ the various technologies so they have the greatest positive impact on healthcare
delivery. The process has yet to been perfected, however, it is informed, and higher
adoption rates will provide the data needed to refine these processes.
Figure 4

(HIMSS Analytics Stage 7 Case Studies, 2015. Retrieved from http://himssanalytics.org).

Adoption Barriers
In their recent (2015) webinar International Data Corporation (IDC) focused on
telemedicine adoption rates. Their forecast regarding patient to provider structures of
telemedicine was eye opening, and emphasized the need to reduce adoption barriers.
They predict that as healthcare costs rise, and focus shifts to quality, forward thinking
healthcare operations will make the shift to “data-driven” hospital strategies. The
prediction that stands out as most relevant to this project is their assertion that 65 percent
of healthcare transactions will be conducted via mobile device by 2018, making web and
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smart mobile device applications key components for future industry success (“IDC:
Analyze The Future,” 2015. Retrieved from http://www.idc.com).
The literature also paints a compelling picture of the important role available
technology can play in improving the delivery of patient care more affordably. At the
same time, next-generation telemedicine utilization rates are still quite low, and there are
several reasons for this.
Cost: Nearly all research cites as the lack of reimbursement as the biggest
challenge facing Telemedicine. A successful Telemedicine program requires considerable
up-front investment and in many cases reorganization of the clinical workflow. There is
an upfront cost of new technology, and the work to integrate the telemedicine build into
existing EHRs and to establish interoperability, require significant investment of financial
and human resources. Lack of a defined reimbursement model often makes the risk
inherent in initial purchase easier to see than the potential return on investment.
Cost benefit: Both providers and payers need clear evidence that shows the
economic and clinical benefits of telemedicine usage. While there are numerous
documented successes employing this technology, the research literature tends to be
limited to proving evidence based on very specific populations. Both private facilities,
and CMS have released reports indicating substantial economic success, the difficulty
remains in choosing from the best available technology in a particular geographic area
and that will best serve targeted populations. With the limits of reimbursement keeping
many players out of the game, it remains difficult to build a model for
telemedicine integration that demonstrates value to a wide array of providers or networks
(CMS, 2015. Retrieved from http://www.cms.org; Cryer, Shannon, Van Amsterdam, &
Leff, 2012).
Volume of information: Telemedicine stands to produce large amounts of
potentially valuable data, including patient vital signs and symptoms. Some physicians
are worried that this critical information may get lost, misinterpreted by the software, or
go unnoticed in amongst the large amount of streaming information. These sensitivities
make data integration and user/provider interface concerns make the work of design
teams more challenging. Another clinical concern is the complexity of algorithms and
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review protocols for functions like reconciliation of a medication list across multiple
systems. Too much unverified data can also serve to obfuscate, rather than inform the
care delivery process. These concerns lead to a range of varied trust levels and
impressions among the physicians. While many providers support the integration of
technology, some fear overly intricate workflows, and others raise concern for increased
potential of malpractice lawsuits.
Heterogeneous Users: Telemedicine programs can be successful if patients are
engaged and compliant to the clinical process recommended by their healthcare provider.
Research has shown many patients respond favorably to their experience with these
technologies. Their ability to properly interface with, and to maintain their end of the
technology, however, may present a limitation to the success of a telemedicine venture.
Technology is varied, and often target populations are critically ill. In such instances the
builds need incorporate passive design features that can be maintained either remotely, or
by in-home aides. Other patient populations may be required to be highly motivated to
maintain high levels of interaction with their technology. Again, each instance will be
different, and each will have its own set of potential weaknesses. In any case, value is
determined on both user ends of the technology, and each successful model will require
both patients and providers to value, trust, and effectively navigate the technology. There
are many elements required for a successful telemedicine program, and there is a lack of
established process to be emulated.
Interoperability: Two levels of interoperability, or lack thereof, are often
mentioned as barriers to adoption of telemedicine. The first is the wireless
interoperability between the patient-level devices and data storage providers. The concern
is for the ability of such devices to effectively capture the data produced at the patient
level, and store it in the cloud. The company that hosts this data is responsible for the
security as well as the accuracy of the data exchanged or transmitted. The second issue
concerns the interoperability between the stored data and provider’s EHR. The data
captured by a patient’s personal device is often incompatible with their provider’s
information system data protocols; translation is often required before the data can
populate the patient’s medical record. This extra step can be costly and is also another
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potential source of risk. The more times data changes hands, the more costly, less secure,
and less trusted the process and the data become. Telemedicine services requiring the
least external support are more highly valued than those requiring contracted supports.
For example, Continua Health Alliance is an industry consortium of 240 companies
worldwide, with published standardized protocol specifications addressing data collection
and storage. Despite their efforts, the number of devices compliant with their standards is
far less than the number of devices currently available on the market.
Scope of Practice Regulations: Beyond the noted restrictions to qualified
reimbursable telemedicine setups, some states require that physicians be licensed in the
state where patients are treated. This significantly limits the reach of the technology and
the array of available providers.
Critics of the federal regulations, several studies, and local key informants,
describe the quality-based reformation efforts as paradoxical. Major frustrations include
all the barriers noted above, as well as the volume of overlooked detail that has resulted
in disjointed policies governing telemedicine. One example illustrating this paradox is
Meaningful Use policies that require patient level scheduling ability to be written into
any personal health record (PHR) service. The interoperability required for this function
has effectively halted PHR development. Such seemingly minor misalignments of policy
detail can create significant implementation barriers for the industry.
These gaps and uncertainty substantially increase cost, and lessen adoption rates
for HIT. Absent a reimbursement structure akin to the MSSP system, smaller providers
like PCMH are faced with the need to absorb the high up-front cost of the technology
investment, with less potential for a positive return on their investment. These same
smaller providers are also under increasing pressure for more and better information as
insurance companies begin to rank providers and advertise their performance. These new
incentive structures can have positive or negative impact on smaller providers position
within the local market. As a result smaller facilities, and those providers less able to
compete, have few choices other than to become subsidiaries of larger systems if they
wish to be part of local PCMH networks.
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Summary of Findings
The literature available regarding telemedicine is largely designed to demonstrate
potential value through improving access, quality, and efficiency of care delivery.
Telemedicine seems to be an excellent way to reduce cost while improving access to
quality healthcare. It has the potential to have profound positive impact on many areas of
the healthcare industry, by unburdening overloaded acute care systems, as well as
improving primary care and remote, in-home, and emergency medical care. It also holds
great value for the emerging quality-health care delivery models responding to current
reform initiatives. This study revealed that the agencies and regulatory bodies driving
healthcare reform are the very same that constrain the growth and integration of the
technology poised to deliver these improvements. The value of bringing technology into
healthcare is widely apparent. Digitizing data serves to better inform the patient as well
as the provider, while data analytics hold the potential to improve the speed and quality
of clinical decision-making. Without a means to cover the costs, however, telemedicine
will remain simply a potential tool, rather than a valuable part of the process.
Learning With Live HIT Systems
Through researching telemedicine, it has become apparent that technology
advances at a far more rapid pace than industry capacity. The scope of care delivery is
vast, complex, and remains fragmented despite the best efforts of very innovative and
passionate teams of creative minds. As new software and devices are created, so must
new process be created to integrate the functions of that new technology. Weeding
through the available software and hardware, and committing to the integration of new
technology and process into a system that can never be suspended, is an expensive and
daunting task. At the same time, healthcare delivery systems are expected to fund, build,
redefine workflow, and simultaneously evaluate the performance for new HIT. It is
unrealistic to expect these same systems to bear the burden and expense of independent
research and evaluation of these new approaches. Unfortunately, these realities contribute
to the shortage of evidence-based research within telemedicine literature.
The Challenge of Data Exchange Protocols
Despite the undeniable virtues of interoperable collaborative healthcare, many
current HIT systems are not built to support complicated file transfer protocols and
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needed interface security measures. As a result, complications frequently arise due to the
firewalls and other private network features, which make it virtually impossible for many
healthcare networks to transfer data out of network. This is especially true with regard to
proprietary personal devices. As long as HIT systems remain fragmented, true integration
of telemedicine technology will be an uphill battle.
Regulation and Payment Reform
For telemedicine to become a true part of U.S. healthcare delivery, state and
federal regulatory bodies need to work with the HIT and analytics experts. This
collaboration is vital to the success of healthcare reform. Regulations can be modernized
to support the integration and utilization of telemedicine technologies, rather than limit,
or prohibit it. In order for the innovative technologies, telemedicine devices, and software
discussed in this work to be utilized at full potential, CMS must develop a payment
structure that will support the various HIT models that can best serve quality based care
delivery. Based on previous funding policy experience, private insurance providers can
be expected follow suit with policies reflecting federal decisions on these matters.
Advances
Despite a long list of barriers, it is important to note several positive advances that
offer a brighter light for the future of telemedicine. The Office of the National
Coordinator for Health Information Technology (ONC) is now explicitly charged with
promoting a national HIT infrastructure and overseeing its development. Private sector
health service research entities like the RAND Corporation are working to increase the
standards of interoperability by working with health information exchange programs on
the state and federal levels. The efforts of these organizations, along with the FDA’s
championing mobile technology’s reclassification as clinical devices, and the growing
number of telemedicine models and devices being marketed, are all contributing to the
growing momentum for HIT advances, despite the barriers identified here.
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Conclusions
The potential for data driven, hi-tech healthcare delivery exists. With backing of
federal policy, and a supportive reimbursement and payment structures, telemedicine
technology will help the HIT industry move up to the next level of adoption and
integration.
From discussions with thought leaders in Maine and review of the literature, three
core elements emerge as necessary parameters required for advancing telemedicine as a
meaningful component of healthcare delivery.
First: The value of the technology in health care delivery is dyadic and application
specific. No one technology will serve the entire industry, or the general public. For
telemedicine to significantly increase access to care, it must be designed to fluidly meet
the specific needs of targeted populations, providers, and their EHRs. Once these
prerequisites are addressed, this technology stands to dramatically increase patient access
to clinical care. The win will be in the integration and sharing of data among these
systems and standardization
Second: To fully trust the data, each new telemedicine build has a process
validation period before produced data are trusted and clinically actionable. As the new
telemedicine technologies and interfaces considered here generate data remotely and at
the patient level, its validation period can be expected to take longer and be more
involved than other earlier HIT applications. While the benefits are currently apparent to
some, further documentation of the evidence of success will do much to more clearly
demonstrate telemedicine’s potential for enhancing quality care delivery.
Third: High initial costs, lack of reimbursement structures, and confounding
regulations significantly limit telemedicine’s perceived immediate value. The literature
indicates that as development and integration gather momentum, telemedicine stands to
free up valuable provider time and resources, while also reducing costly events such as
hospital readmissions. When incorporated into such health care delivery models as
Patient Centered Medical Home, and Accountable Care Organization structures, this
technology can be expected to play a more central role and contribute to improved patient
experience and care quality, while reducing the cost of care delivery.
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The need for and potential impact of telemedicine in Maine places local providers
at the forefront of change. According to federal classification schemes, used to determine
eligibility for programs that assist with healthcare delivery, 11 of Maine's 16 counties are
considered rural areas. In 2014, this represents 552,638 residents - or 42% of Maine's
population. In addition, Maine is considered the oldest state in the nation, and the oldest
residents are often living in our rural counties, counties that are known to have the lowest
median income and the fewest number of healthcare providers. These demographic
imperatives make development of HIT the infrastructure within the Maine healthcare
system a vital process. Such infrastructure, incorporating strong, evidence based
telemedicine models, with specific design features to serve the needs of rural Maine
residents, can be expected to have a long run positive impact on overall access to care,
elevating community health, while decreasing cost, for both the patient and their
providers (Maine Rural Health, 2015. Retrieved on http://www.maine.gov).
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